Bg pattern

NAAXIA 38 mg/ml EYE DROPS SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use NAAXIA 38 mg/ml EYE DROPS SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Naaxia 38 mg/ml eye drops in solution

Sodium Espaglucide

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack:

  1. What is Naaxia and what is it used for
  2. What you need to know before you use Naaxia
  3. How to use Naaxia
  4. Possible side effects
  5. Storing Naaxia
  6. Contents of the pack and other information

1. What is Naaxia and what is it used for

Naaxia is an eye drop solution for ophthalmic use, which has a broad-spectrum anti-allergic activity and allows the treatment of allergic conditions in the eyes without presenting the risks associated with corticosteroid therapy.

It is used for the treatment of conjunctivitis and blepharoconjunctivitis (inflammation of the conjunctiva and eyelids) of allergic origin.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Naaxia

Do not use Naaxia

  • if you are allergic to sodium espaglucide or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before you start using Naaxia.

Naaxia is presented as eye drops and should be used via the ophthalmic route.

Do not inject or ingest.

Using Naaxia with other medicines

Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.

The efficacy of the eye drops may be altered by simultaneous instillation with another eye drop. In this case, wait 10 minutes before performing the second instillation.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

Pregnancy

As a general rule, the use of Naaxia is not recommended during the first three months of pregnancy.

Breastfeeding

The use of Naaxia is not recommended during breastfeeding.

Driving and using machines

You may notice blurred vision immediately after applying Naaxia. Do not drive or use machines until this effect has disappeared.

3. How to use Naaxia

Follow exactly the administration instructions of Naaxia given by your doctor or pharmacist. If you are in doubt, consult your doctor or pharmacist again.

The recommended dose is:

Adults and children:1 drop 4 times a day in the conjunctival sac of each eye.

The Naaxia packaging incorporates a new technology for the sterile supply of the product, called the ABAK system.

Wash your hands carefully before proceeding to apply and avoid any contact of the dropper with your fingers and the surface of the eye or any other.

Check that the packaging seal is intact.

Open the packaging, making sure that the cap and dropper do not touch any surface.

With your head tilted back, pull down the lower eyelid and instill 1 drop into the conjunctival sac (space between the eye and the eyelid) of each eye while looking up.

Gently close your eyes and keep them closed for a few moments.

Replace the cap on the bottle after each use.

Before using other ophthalmic medications, wait at least 10 minutes.

Since these are sterile specialties, it is recommended to follow the following instructions:

- Each patient will use their own packaging.

- After finishing the treatment, the medication should be discarded even if it has not been fully consumed.

If you use more Naaxia than you should

No cases of topical overdose have been reported.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.

If you forget to use Naaxia

At the moment you realize you have forgotten, apply one drop to each eye and continue with the normal treatment frequency.

Do not use a double dose to make up for forgotten doses.

If you stop using Naaxia

In order to optimize the success of the treatment, it is important to continue it for the time indicated by the doctor, even if the symptoms disappear.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

At the time of instillation, a temporary stinging sensation may occur.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storing Naaxia

Keep out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date is the last day of the month shown.

Discard 3 months after first opening the packaging.

Medicines should not be disposed of via wastewater or household waste. Return the packaging and any unused medicine to a pharmacy. Ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.

6. Contents of the pack and other information

Composition of Naaxia

  • The active substance is sodium espaglucide. Each ml of solution contains 38 mg of sodium espaglucide.
  • The other ingredients are: sodium hydroxide or hydrochloric acid (pH adjuster) and water for injectable preparations.

Appearance and packaging of the product

Naaxia is presented as a solution packaged in 10 ml plastic bottles.

Marketing authorisation holder and manufacturer

Marketing authorisation holder

Laboratorios Thea S.A, C/ Enric Granados nº 86-88, 2ª planta, 08008 - Barcelona

Manufacturer

EXCELVISION, Rue de la Lombardière, BP 131 - 07100 Annonay - France

Or

FARMILA Thea Farmaceutici S.p.A, Via E. Fermi, 50- 20019 Settimo Milanese (MI)- Italy

This leaflet was last revised in March 2016

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/

Online doctors for NAAXIA 38 mg/ml EYE DROPS SOLUTION

Discuss questions about NAAXIA 38 mg/ml EYE DROPS SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for NAAXIA 38 mg/ml EYE DROPS SOLUTION?
NAAXIA 38 mg/ml EYE DROPS SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in NAAXIA 38 mg/ml EYE DROPS SOLUTION?
The active ingredient in NAAXIA 38 mg/ml EYE DROPS SOLUTION is spaglumic acid. This information helps identify medicines with the same composition but different brand names.
How much does NAAXIA 38 mg/ml EYE DROPS SOLUTION cost in pharmacies?
The average pharmacy price for NAAXIA 38 mg/ml EYE DROPS SOLUTION is around 4.81 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures NAAXIA 38 mg/ml EYE DROPS SOLUTION?
NAAXIA 38 mg/ml EYE DROPS SOLUTION is manufactured by Laboratorios Thea S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of NAAXIA 38 mg/ml EYE DROPS SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether NAAXIA 38 mg/ml EYE DROPS SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to NAAXIA 38 mg/ml EYE DROPS SOLUTION?
Other medicines with the same active substance (spaglumic acid) include AFLUON 0.5 mg/ml EYE DROPS SOLUTION, APADIN 1 mg/ml EYE DROPS SOLUTION, AZELASTINE ABAMED 0.5 mg/ml EYE DROPS SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media